Caris Life Sciences receives MolDX approval for Caris ChromoSeq, advancing access to comprehensive genomic profiling for myeloid malignancies

Published: 2026-05-04 08:39:41 ET CAI

Published on 05/04/2026 at 08:39 am EDT